Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Accenture
Dow
Fish and Richardson
Medtronic
Teva
Argus Health
QuintilesIMS
Harvard Business School

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,236,838

« Back to Dashboard

Summary for Patent: 5,236,838
Title: Enzymatically active recombinant glucocerebrosidase
Abstract:Recombinant enzymatically active glucocerebrosidase is produced by a eukaryotic cell. Also, a cell includes nucleic acid encoding enzymatically active glucocerebrosidase; also a eukaryotic organism contains such a cell. Also, a method for producing enzymatically active glucocerebrosidase includes steps of introducing glucocerebrosidase-encoding nucleic acid into a eukaryotic cell, causing the cell to express glucocerebrosidase, and purifying the glucocerebrosidase from the cell.
Inventor(s): Rasmussen; James (Boston, MA), Barsomian; Gary (Georgetown, MA), Bergh; Michel (Belmont, MA)
Assignee: Genzyme Corporation (Cambridge, MA)
Application Number:07/748,283
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,236,838
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,236,838

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,236,838

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 138686 ➤ Try a Free Trial
Canada 2006709 ➤ Try a Free Trial
Canada 2339888 ➤ Try a Free Trial
Germany 68926569 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Mallinckrodt
US Department of Justice
Merck
Covington
UBS
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.